EUVIMED · CrossrefJournal
Neuro-Oncology Pediatrics
ISSN 2977-4454 · Oxford University Press (OUP)
Latest articles
High-Precision Radiotherapy Preserves Neurocognitive and Endocrine Function with Favorable Impact on Survival in Pediatric and Adolescent Low-Grade Gliomas
Utility of Cerebrospinal Fluid Liquid Biopsy in Recurrent Pediatric Medulloblastoma: Case Series and Literature Review
Atypical Teratoid Rhabdoid Tumor Across Two Decades: Real-World Outcomes from a Latin-American Institution
Early-onset sonic hedgehog medulloblastomas with Smoothened (SMO) activating pathogenic variants: wouldn’t underlying post-zygotic mosaicism be underdiagnosed?
Genomic landscape and clinical predictors of germline variants in pediatric CNS tumors in a highly consanguineous population
A Phase I Trial of the ADAM-10 inhibitor, INCB007839, in Children with Recurrent/Progressive High-Grade Gliomas: A Report from the Pediatric Brain Tumor Consortium (PBTC-056)
Prevalence of MUTYH germline variants in Pediatric and Adolescent/Young Adult Patients with a Brain Tumor
Clinical, Sociodemographic, and Neighborhood Factors Associated with Delayed Initial Neuroimaging in Children with Posterior Fossa Tumors
Preclinical efficacy and mechanism of action of dordaviprone in H3 K27M-mutant diffuse glioma
Pre-treatment Monocytosis in Pediatric H3K27M-Mutant Gliomas
A Phase I Feasibility Trial of Tumor Treating Fields Therapy with Temozolomide and Bevacizumab in Pediatric High-Grade Glioma
Comparable Survival Outcomes and Reduced Risk of Low-Dose Whole-ventricle Radiation Therapy with Chemotherapy in Central Nervous System Germinomas
Ataxia in children with posterior fossa tumours: a prospective European multicentre cohort study
ID #18 CHD7-associated CHARGE Syndrome and a spinal schwannoma with a SH3PXD2A::HTRA1 fusion: A case report
ID #40 Pre-treatment journey and outcome for children with intracranial non-germinomatous germ cell tumors – the Shanghai experience
ID #43 Exploring morphometric, lesion and texture-based analysis of MRI signatures in paediatric spinal cord tumours
ID #55
ID #56 Can AI inform decision-making in pediatric neuro-oncology?
ID #58 A NATIONWIDE EVALUATION OF MAPK INHIBITORS FOR PAEDIATRIC LOW-GRADE GLIOMA IN THE UNITED KINGDOM: SAFETY, EFFICACY, VISUAL MORBIDITY, AND OUTCOMES.
ID #59 Life After Paediatric Low-Grade Glioma: The Utility Of Survivor Narratives In Paediatric Low-Grade Glioma Outcome Research
ID #63 Pediatric Meningiomas, case series.
ID #68 Inhibithors of mTOR in Tumor-Associated-Epilepsy
ID #69 APC Mutations and Brain Cancer Risk
ID #70 Oncogenetic and Reproductive Management in TSC
ID #71 Ranjan J. Perera Department of Neurosurgery and Oncology, Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, 1650 Orleans St., Baltimore, MD 21231 Johns Hopkins All Children’s Hospital, 600 5th St. South, St. Petersburg, FL 33701
ID #82 Molecular and Cellular Diversity in Pediatric Low-Grade Glioma: Insights from Matched Primary / Recurrent Samples.
ID #88 Recurrence Predictors in Operated Cases of Craniopharyngioma
ID #92 Global neurosurgery focuses on improving access to specialized neurosurgical care in underserved and resource-limited regions. It involves training local surgeons, developing infrastructure, and fostering sustainable healthcare policies. This approach aims to reduce neurological health disparities worldwide through long-term capacity building and international collaboration such as the Bogota Declaration.
ID #93 Your patients are our patients: embedding fertility preservation conversations into neuro-oncology pathways
ID #95 Dual polyamine pathway blockade synergises with irinotecan to eradicate MYC-driven medulloblastoma
EUVIMED